JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test sale cost 4400 AED
PRDM16 Gene Cardiomyopathy dilated type 1LL Genetic Test sale cost 4400 AED PRDM16 Gene Cardiomyopathy dilated type 1LL Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
PLN Gene Cardiomyopathy hypertrophic type 18 Genetic Test sale cost 4400 AED PLN Gene Cardiomyopathy hypertrophic type 18 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The JPH2 Gene Cardiomyopathy Familial Hypertrophic Type 17 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the JPH2 gene, which are implicated in the development of Familial Hypertrophic Cardiomyopathy (FHC) Type 17. This condition is a form of heart disease characterized by the thickening of the heart muscle, potentially leading to heart failure and sudden cardiac death. Early detection through genetic testing can be crucial for managing the condition, guiding treatment options, and informing at-risk family members about their genetic predisposition.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient’s DNA to detect specific mutations in the JPH2 gene. The process is meticulous, ensuring high accuracy and reliability in the results. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results.

For individuals with a family history of cardiomyopathy or symptoms indicative of the condition, this genetic test provides a vital tool for early intervention and personalized care planning. By understanding one’s genetic makeup, patients and healthcare providers can work together to monitor heart health more closely and take preventive measures to mitigate the risks associated with Familial Hypertrophic Cardiomyopathy Type 17.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test

At DNA Labs UAE, we offer the JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test. This test is designed to detect specific genetic mutations associated with hypertrophic cardiomyopathy (HCM) caused by mutations in the JPH2 gene.

Test Components and Price

The JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology to identify specific mutations in the JPH2 gene.

Test Type and Doctor

The JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a Cardiologist for this test.

Test Department and Pre Test Information

The JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test is conducted in our Genetics department. Before undergoing the test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by JPH2 Gene Cardiomyopathy familial hypertrophic type 17 NGS Genetic DNA Test.

Test Details

JPH2 gene cardiomyopathy, familial hypertrophic type 17 is a specific genetic mutation that leads to hypertrophic cardiomyopathy (HCM). HCM is characterized by the thickening of the heart muscle, resulting in impaired heart function.

The JPH2 gene is responsible for producing a protein called junctophilin-2, which plays a crucial role in the normal functioning of heart muscle cells. Mutations in the JPH2 gene can disrupt the production or function of junctophilin-2, leading to the development of HCM.

NGS (Next-Generation Sequencing) genetic testing is used to identify genetic mutations by sequencing an individual’s DNA. In the case of JPH2 gene cardiomyopathy, familial hypertrophic type 17, NGS genetic testing can detect specific mutations in the JPH2 gene associated with HCM development.

The identification of these mutations through NGS genetic testing enables the diagnosis of individuals with JPH2 gene cardiomyopathy, familial hypertrophic type 17 and provides valuable information about the risk of developing HCM in family members. This information is crucial for genetic counseling, early detection, and potentially targeted treatment strategies.

Test Name JPH2 Gene Cardiomyopathy familial hypertrophic type 17 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for JPH2 Gene Cardiomyopathy, familial hypertrophic type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with JPH2 Gene Cardiomyopathy, familial hypertrophic type 17 NGS Genetic DNA Test gene JPH2
Test Details

JPH2 gene cardiomyopathy, familial hypertrophic type 17 is a specific type of genetic mutation that causes hypertrophic cardiomyopathy (HCM). HCM is a condition characterized by the thickening of the heart muscle, leading to impaired heart function.

The JPH2 gene provides instructions for producing a protein called junctophilin-2, which is involved in the normal functioning of heart muscle cells. Mutations in the JPH2 gene can disrupt the production or function of junctophilin-2, leading to the development of HCM.

NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic mutations by sequencing a person’s DNA. In the case of JPH2 gene cardiomyopathy, familial hypertrophic type 17, NGS genetic testing can be used to detect specific mutations in the JPH2 gene that are associated with the development of HCM.

By identifying these mutations, NGS genetic testing can help diagnose individuals with JPH2 gene cardiomyopathy, familial hypertrophic type 17 and provide information about the risk of developing HCM in family members. This information can be used for genetic counseling, early detection, and potentially targeted treatment strategies.

SKU: TEST-3400 Category:

Related products